Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02292979 |
|---|---|
| Brief Title: | Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. (BREACH) |
| First Submitted : | October 28, 2014 |
| First Submitted that Met QC Criteria : | November 13, 2014 |
| First Posted : | November 18, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 18, 2022 |
| Last Update Posted : | August 19, 2022 |